Identification of HSP105 as a novel non-Hodgkin lymphoma restricted antigen

被引：0
|
作者：
Pupa, S. M. [1 ]
Zappasodi, R. [1 ]
Ghedini, G. C. [1 ]
Castagnoli, L. [1 ]
Aiello, P. [1 ]
Micciche, F. [1 ]
Cabras, A. D. [1 ]
Bongarzone, I. [1 ]
Gianni, A. M. [1 ]
机构：
[1] Fdn IRCCS, Inst Nazl Tumori, Milan, Italy
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)72309-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [1] SEROLOGICAL IDENTIFICATION OF HSP105 AS A NOVEL NON-HODGKIN LYMPHOMA ASSOCIATED ANTIGEN
    Di Nicola, M.
    Zappasodi, R.
    Ghedini, G. C.
    Bongarzone, I.
    Castagnoli, L.
    Cabras, A. D.
    Tripodo, C.
    Messina, A.
    Tortoreto, M.
    Pupa, S. M.
    Gianni, A. M.
    ANNALS OF ONCOLOGY, 2011, 22 : 201 - 201
  • [2] Serological Identification of HSP105 as a Novel Non-Hodgkin Lymphoma Therapeutic Target
    Zappasodi, Roberta
    Ghedini, Gaia C.
    Bongarzone, Italia
    Castagnoli, Lorenzo
    de Bortoli, Maida
    Aiello, Piera
    Cavane, Alessandra
    Cabras, Antonello D.
    Carlo-Stella, Carmelo
    Gianni, Alessandro M.
    Pupa, Serenella M.
    Di Nicola, Massimo
    BLOOD, 2010, 116 (21) : 207 - 207
  • [3] Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target
    Zappasodi, Roberta
    Bongarzone, Italia
    Ghedini, Gaia C.
    Castagnoli, Lorenzo
    Cabras, Antonello D.
    Messina, Antonella
    Tortoreto, Monica
    Tripodo, Claudio
    Magni, Michele
    Carlo-Stella, Carmelo
    Gianni, Alessandro M.
    Pupa, Serenella M.
    Di Nicola, Massimo
    BLOOD, 2011, 118 (16) : 4421 - 4430
  • [4] Identification of HSP105 as a novel B-cell non-Hodgkin lymphoma (NHL) antigen (ag)
    Zappasodi, R.
    Pupa, S.
    Bongarzone, I.
    Ghedini, G. C.
    Castagnoli, L.
    Micciche, F.
    Cabras, A.
    Carlo-Stella, C.
    Gianni, A. M.
    Di Nicola, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] HSP105 inhibition hampers the growth of human aggressive B-cell non-Hodgkin lymphoma by counteracting key oncogenic pathways
    Zappasodi, R.
    Cavane, A.
    Tortoreto, M.
    Tringali, C.
    Cabras, A. D.
    Ruggiero, G.
    Castagnoli, L.
    Venerando, B.
    Zaffaroni, N.
    Pupa, S. M.
    Gianni, A. M.
    Di Nicola, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S431 - S432
  • [6] HSP105 Inhibition Counteracts Key Oncogenic Pathways and Hampers the Growth of Human Aggressive B-Cell Non-Hodgkin Lymphoma
    Zappasodi, Roberta
    Cavane, Alessandra
    Tortoreto, Monica
    Tringali, Cristina
    Ruggiero, Giusi
    Castagnoli, Lorenzo
    Venerando, Bruno
    Zaffaroni, Nadia
    Pupa, Serenella M.
    Gianni, Alessandro Massimo
    Di Nicola, Massimo
    BLOOD, 2012, 120 (21)
  • [7] Novel therapies for non-Hodgkin Lymphoma
    Vose, Julie M.
    ANNALS OF ONCOLOGY, 2015, 26 : 17 - 17
  • [8] IDENTIFICATION OF NOVEL EPIGENETICALLY SILENCED TUMOUR SUPPRESSOR GENES IN HODGKIN AND NON-HODGKIN LYMPHOMA
    Roehrs, S.
    Romani, J.
    Rosenwald, A.
    Dirks, W.
    Drexler, H. G.
    Quentmeier, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 233 - 233
  • [9] The role of novel immunotherapies in non-Hodgkin lymphoma
    Pishko, Allyson
    Nasta, Sunita D.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (01) : 93 - 103
  • [10] Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
    Grover, Natalie S.
    Park, Steven I.
    PHARMACEUTICALS, 2015, 8 (03) : 607 - 636
12345